Kevin Chatham‐Stephens
A5037546147- Botulinum Toxin and Related Neurological Disorders
- Vaccine Coverage and Hesitancy
- SARS-CoV-2 and COVID-19 Research
- COVID-19 epidemiological studies
- Neurological disorders and treatments
- Smoking Behavior and Cessation
- Bacillus and Francisella bacterial research
- Chronic Obstructive Pulmonary Disease (COPD) Research
- Herpesvirus Infections and Treatments
- Poisoning and overdose treatments
- Poxvirus research and outbreaks
- Respiratory viral infections research
- Heavy Metal Exposure and Toxicity
- Influenza Virus Research Studies
- Pneumonia and Respiratory Infections
- COVID-19 Clinical Research Studies
- Environmental Justice and Health Disparities
- Hereditary Neurological Disorders
- Healthcare and Environmental Waste Management
- COVID-19 and Mental Health
- Antibiotic Resistance in Bacteria
- Drug-Induced Hepatotoxicity and Protection
- Child and Adolescent Health
- Streptococcal Infections and Treatments
- Salmonella and Campylobacter epidemiology
Centers for Disease Control and Prevention
2014-2024
National Center on Birth Defects and Developmental Disabilities
2019-2024
National Center for Immunization and Respiratory Diseases
2024
United States Virgin Islands Department of Health
2023
Zel Technologies (United States)
2022
General Dynamics (United States)
2022
Computer Emergency Response Team
2022
National Center for Emerging and Zoonotic Infectious Diseases
2017-2021
Fundação Armando Alvares Penteado
2020
Center for Global Health
2019
An estimated 30 million passengers are transported on 272 cruise ships worldwide each year* (1). Cruise bring diverse populations into proximity for many days, facilitating transmission of respiratory illness (2). SARS-CoV-2, the virus that causes coronavirus disease (COVID-19) was first identified in Wuhan, China, December 2019 and has since spread to at least 187 countries territories. Widespread COVID-19 been reported as well (3). Passengers certain ship voyages might be aged ≥65 years,...
On December 31, 2019, Chinese health officials reported a cluster of cases acute respiratory illness in persons associated with the Hunan seafood and animal market city Wuhan, Hubei Province, central China. January 7, 2020, confirmed that novel coronavirus (2019-nCoV) was this initial (1). As February 4, total 20,471 cases, including 2,788 (13.6%) severe illness,* 425 deaths (2.1%) had been by National Health Commission China (2). Cases have also 26 locations outside mainland China,...
CDC, the Food and Drug Administration (FDA), state local health departments, public clinical partners are investigating a multistate outbreak of lung injury associated with use electronic cigarette (e-cigarette), or vaping, products. In late August, CDC released recommendations for care providers regarding e-cigarette, product (EVALI) based on limited data from first reported cases (1,2). This report summarizes national surveillance describing features more recently interim these U.S. caring...
In December 2019, a cluster of cases pneumonia emerged in Wuhan City central China's Hubei Province. Genetic sequencing isolates obtained from patients with identified novel coronavirus (2019-nCoV) as the etiology (1). As February 4, 2020, approximately 20,000 confirmed had been China and an additional 159 23 other countries, including 11 United States (2,3). On January 17, CDC U.S. Department Homeland Security's Customs Border Protection began health screenings at airports to identify ill...
The Summary of Notifiable Infectious Diseases and Conditions-United States, 2014 (hereafter referred to as the summary) contains official statistics, in tabular graphic form, for reported occurrence nationally notifiable infectious diseases conditions United States 2014. Unless otherwise noted, data are final totals June 30, 2015. These statistics collected compiled from reports sent by U.S. state territory, New York City, District Columbia health departments National Surveillance System...
¶ A list of severe manifestations monkeypox can be found at https://emergency
Botulism is a rare, neurotoxin-mediated, life-threatening disease characterized by flaccid descending paralysis that begins with cranial nerve palsies and might progress to extremity weakness respiratory failure. Botulinum neurotoxin, which inhibits acetylcholine release at the neuromuscular junction, produced anaerobic, gram-positive bacterium Clostridium botulinum and, rarely, related species (C. baratii C. butyricum). Exposure neurotoxin occurs through ingestion of toxin (foodborne...
Currently, no Food and Drug Administration (FDA)-approved treatments for human monkeypox are available. Tecovirimat (Tpoxx), however, is an antiviral drug that has demonstrated efficacy in animal studies FDA-approved treating smallpox. Use of tecovirimat treatment the United States permitted only through FDA-regulated Expanded Access Investigational New (EA-IND) mechanism. CDC holds a nonresearch EA-IND protocol facilitates access to use monkeypox.§ The includes patient adverse event...
COVID-19 remains an important public health threat, despite overall decreases in COVID-19-related severe disease since the start of pandemic. COVID-19-associated hospitalization rates remain higher among adults aged ≥65 years relative to younger adults, adolescents, and children; during October 2023-January 2024, 67% all hospitalizations were persons years. On September 12, 2023, CDC's Advisory Committee on Immunization Practices (ACIP) recommended updated (2023-2024 Formula) vaccination...
CDC, the Food and Drug Administration, state local health departments, other public clinical stakeholders are investigating a national outbreak of electronic-cigarette (e-cigarette), or vaping, product use-associated lung injury (EVALI) (1). As October 22, 2019, 49 states, District Columbia (DC), U.S. Virgin Islands have reported 1,604 cases EVALI to including 34 (2.1%) EVALI-associated deaths in 24 states. Based on data collected as 15, this report updates patient characteristics substances...
In February 2018, a typhoid fever outbreak caused by Salmonella enterica serotype Typhi (Typhi), resistant to chloramphenicol, ampicillin, trimethoprim-sulfamethoxazole, fluoroquinolones, and third-generation cephalosporins, was reported in Pakistan. During November 2016-September 2017, 339 cases of this extensively drug-resistant (XDR) strain were Pakistan, mostly Karachi Hyderabad; one travel-associated case also from the United Kingdom (1). More have been detected Hyderabad as...
Abstract Introduction More than 93,000 cases of coronavirus disease (COVID-19) have been reported worldwide. We describe the epidemiology, clinical course, and virologic characteristics first 12 U.S. patients with COVID-19. Methods collected demographic, exposure, information from confirmed by CDC during January 20–February 5, 2020 to Respiratory, stool, serum, urine specimens were submitted for SARS-CoV-2 rRT-PCR testing, virus culture, whole genome sequencing. Results Among patients,...
As of January 7, 2020, a total 2558 hospitalized patients with nonfatal cases and 60 fatal e-cigarette, or vaping, product use-associated lung injury (EVALI) had been reported to the Centers for Disease Control Prevention (CDC).In national study, we compared characteristics EVALI those improve ability clinicians identify at increased risk death from condition. Health departments CDC included, when available, data medical-record abstractions patient interviews. Analyses included all that were...
CDC, the Food and Drug Administration (FDA), state local health departments, public clinical stakeholders are investigating a nationwide outbreak of e-cigarette, or vaping, product use-associated lung injury (EVALI) (1). As November 13, 2019, 49 states, District Columbia, two U.S. territories (Puerto Rico Virgin Islands) have reported 2,172 EVALI cases to including 42 (1.9%) EVALI-associated deaths. To inform surveillance, during 2019-20 influenza season, case report information supplied by...
CDC, the Food and Drug Administration (FDA), state local health departments, public clinical stakeholders are investigating a nationwide outbreak of e-cigarette, or vaping, product use-associated lung injury (EVALI) (1). CDC has published recommendations for care providers regarding EVALI (2-4). Recently, researchers from Utah New York proposed diagnosis treatment algorithms (5,6). remains exclusion because, at present, no specific test marker exists its diagnosis, evaluation should be...
Although severe COVID-19 illness and hospitalization are more common among older adults, children can also be affected (1). More than 3 million cases of had been reported infants aged <5 years (children) as December 2, 2022 (2). One in four hospitalized with required intensive care; 21.2% COVID-19-related multisystem inflammatory syndrome (MIS-C) occurred 1-4 years, 3.2% MIS-C <1 year (1,3). On June 17, 2022, the Food Drug Administration issued an Emergency Use Authorization (EUA) Moderna...
A multistate measles outbreak, predominantly affecting members of close-knit communities with low vaccination coverage in New Mexico, Oklahoma, and Texas began January 2025. As April 17, a total 800 cases have been reported the United States 2025; 654 (82%) associated ongoing outbreak. These represent an approximately 180% increase over 285 during all 2024, second highest annual case count 25 years. Overall, 771 (96%) patients unvaccinated or had unknown status (77% were unvaccinated, 14%...
Since May 2022, approximately 20,000 cases of monkeypox have been identified in the United States, part a global outbreak occurring 90 countries and currently affecting primarily gay, bisexual, other men who sex with (MSM) (1). Monkeypox virus (MPXV) spreads from person to through close, prolonged contact; small number occurred populations are not MSM (e.g., women children), testing is recommended for persons meet suspected case definition* CDC previously developed five real-time polymerase...
On October 29, 2021, the Pfizer-BioNTech pediatric COVID-19 vaccine received Emergency Use Authorization for children aged 5-11 years in United States.† For a successful immunization program, both access to and uptake of are needed. Fifteen million doses were initially made available providers ensure broadest possible estimated 28 eligible years, especially those high social vulnerability index (SVI)§ communities. Initial supply was strategically distributed maximize vaccination...
We analyzed first-dose coronavirus disease vaccination coverage among US children 5-11 years of age during November-December 2021. Pediatric varied widely by jurisdiction, group, and race/ethnicity, lagged behind for adolescents aged 12-15 the first 2 months vaccine rollout.
During the 2023-24 respiratory virus season, Advisory Committee on Immunization Practices recommends influenza and COVID-19 vaccines for all persons aged ≥6 months, syncytial (RSV) vaccine is recommended ≥60 years (using shared clinical decision-making), pregnant persons. Data from National Survey-Adult COVID Module, a random-digit-dialed cellular telephone survey of U.S. adults ≥18 years, are used to monitor influenza, COVID-19, RSV vaccination coverage. By December 9, 2023, an estimated...